Myasthenia Gravis (MG) is a rare and chronic autoimmune disorder that affects the neuromuscular junction—the connection between the nerves and muscles. The hallmark of MG is muscle weakness, particularly in the eye muscles, face, throat, and limbs, which worsens with activity and improves with rest. MG can impact a person’s ability to perform everyday activities and, in severe cases, can cause life-threatening complications, such as respiratory failure.
With the advancements in medical science, the question arises: Can Myasthenia Gravis be cured? While the answer is nuanced, understanding the nature of the disease and the treatments available can offer hope and clarity for those living with MG.
Contents
Understanding Myasthenia Gravis
The nervous system communicates with muscles in a healthy body through a neurotransmitter called acetylcholine. Acetylcholine is released from nerve endings and binds to receptors on muscle cells, triggering contraction. In Myasthenia Gravis, the immune system mistakenly produces antibodies that block, alter, or destroy acetylcholine receptors on the muscles. This interference prevents the muscles from receiving the signals they need to function properly, leading to weakness.
The severity of Myasthenia Gravis can vary significantly from person to person. Symptoms typically include:
